catalyst
as of 2026-05-12LB-102 — Adjunctive MDD (Ph2) trial initiation
at a glance
2027-02-01 · Guided (guided) — Company-guided and directional — subject to change.
Synthesized from structured facts only — each point cited above.
Event
What
LB-102 — Adjunctive MDD (Ph2) trial initiation
Type
Guided Milestone
Date
2027-02-01
Date type
GUIDED guided
Guided window
early 2027
company-GUIDED date (directional, subject to change); not an actual/settled event
Company-guided and directional — subject to change. This date is directional and must not be read as settled.
relationships
The graph out of here
affected drug
drug